is berberine a glp-1 receptor agonist Frontiers Berberine as a multi-target therapeutic

PMID: 37873318

Future research directions include direct comparative trials between various GLP-1 RAs and multi-agonists in MASLD populations to identify optimal therapeutic choices for specific patient subgroups

In vivo experiments showed the peptide rapidly restoring blood flow through collateral vessel activation in models of venous occlusion, an effect closely linked to the NO system and reduction of free radical formation

It enhances insulin secretion, suppresses glucagon release, and slows gastric emptying, which helps control blood sugar levels and support weight loss

This can be achieved first and foremost with a thorough medical history, a clinical examination and a battery of tests which can aid the physician in understanding the true nature of illness